The reduction of integrin expression also inhibited thyroxine-induced ERK1/2 activation (Figure 2C), implicating integrin αvβ3 is involved in the activation of MAPK by thyroid hormone in ovarian cancer cells. Here, MAPK3 is linked to ovarian carcinoma.